Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Acrux ( (AU:ACR) ) has issued an update.
Acrux Limited has requested an immediate trading halt for its ordinary shares on the ASX as it finalises the details of a proposed capital raising. The halt will remain in place until either the company releases its capital-raising announcement or normal trading resumes on 11 May 2026, with the board confirming it is unaware of any reason for the halt not to be granted.
The move signals that Acrux is preparing to raise new equity, a step that could strengthen its balance sheet and fund future growth initiatives in its portfolio. Investors will be watching the forthcoming announcement closely for details on the size, structure and pricing of the capital raising and any resulting dilution or strategic benefits.
More about Acrux
Acrux Limited is an Australian-listed company on the ASX under the ticker ACR. The company operates in the healthcare and pharmaceutical sector, focusing on developing and commercialising specialty drug products for global markets.
Average Trading Volume: 279,899
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.52M
Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.